A surge of interest and research in potential alternatives to conventional hormone therapy has taken place. Despite a lack of evidence to support its safety and efficacy, one of those alternatives, Bioidentical Hormone Replacement Therapy (BHRT), has been used for the treatment of male hormonal conditions (e.g., andropause, thyropause, and adrenopause) through the use of bioidentical plant- and extract-based compounds. This Circle aims to remotely collect patient-reported symptoms and health-related, quality-of-life data among male patients pre- and post-administration of BHRT. To collect these data, this Circle will utilize the Aging Male Symptoms Scale (AMS). Enrolled patients will be followed for 18 months following the administration of BHRT and will complete patient-reported outcome measures on a quarterly basis following treatment. The collection of real-world data from this Circle will provide additional evidence in determining the safety and efficacy of BHRT among male patients.
Grant Pagdin MD
FOUNDER
MDBiologix
FUNDER
CIRCLE OBJECTIVE
A surge of interest and research in potential alternatives to conventional hormone therapy has taken place. Despite a lack of evidence to support its safety and efficacy, one of those alternatives, Bioidentical Hormone Replacement Therapy (BHRT), has been used for the treatment of male hormonal conditions (e.g., andropause, thyropause, and adrenopause) through the use of bioidentical plant- and extract-based compounds. This Circle aims to remotely collect patient-reported symptoms and health-related, quality-of-life data among male patients pre- and post-administration of BHRT. To collect these data, this Circle will utilize the Aging Male Symptoms Scale (AMS). Enrolled patients will be followed for 18 months following the administration of BHRT and will complete patient-reported outcome measures on a quarterly basis following treatment. The collection of real-world data from this Circle will provide additional evidence in determining the safety and efficacy of BHRT among male patients.
Circle Protocol
Patient Reported Outcome Measure:
Aging Male Symptoms Scale (AMS)
Intervention:
Bioidentical Hormone Replacement Therapy (BHRT)
Clinical Benefits:
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
Patient Benefits:
Personalized, secure, and simple to use
MEMBER criteria
Require approval to join from Circle Founder, Dr. Grant Pagdin
